Join to View Full Profile
101 Manning DrRm 1107g W WingChapel Hill, NC 27514
Phone+1 919-966-1072
Dr. Sheikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Gastroenterology, 2009 - 2012
UPMC Medical EducationResidency, Internal Medicine, 2004 - 2006
King Edward Medical UniversityClass of 2002
Certifications & Licensure
NC State Medical License 2006 - 2025
PA State Medical License 2004 - 2006
American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Post-operative Crohn's Disease Recurrence and Infectious Complications: A Transcriptomic Analysis.Kevin A Chen, Valerie Gartner, Kimberly C Darlington, Sophie R Silverstein, Meaghan M Kennedy Ng
Digestive Diseases and Sciences. 2025-01-01 - 1 citationsVagal stimulation ameliorates murine colitis by regulating SUMOylation.Ayman Youssef, Ata Ur Rehman, Mohamed Elebasy, Jatin Roper, Shehzad Z Sheikh
Science Translational Medicine. 2024-11-20 - eQTL in diseased colon tissue identifies novel target genes associated with IBD.Nina C Nishiyama, Sophie Silverstein, Kimberly Darlington, Meaghan M Kennedy Ng, Katelyn M Clough
Biorxiv. 2024-10-17
Press Mentions
- Chairman PAC Lauds NGO-Run Free Kidney Dialysis Center at Mirpur DHQ Hospital Services:November 2nd, 2020
Personalizing Crohn’s Disease Therapies with microRNA as IndicatorOctober 4th, 2018
Grant Support
- Multi-omic characterization of genetic variants in IBD risk lociUNIV OF NORTH CAROLINA CHAPEL HILL2024–2028
- High throughput functional studies of IBD-associated GWAS variantsUNIV OF NORTH CAROLINA CHAPEL HILL2023–2027
- Multiomics characterization, induction, and elimination of the HIV gut reservoirJ. DAVID GLADSTONE INSTITUTES2022–2027
- Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's diseaseEPICYPHER, INC.2022–2025
- Development of a microphysiologic system to assay the interaction of the human colonic epithelium on Clostridium difficileUNIVERSITY OF WASHINGTON2020–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
